Charles River Laboratories (CRL) Tops Q1 EPS by 8c; Boosts Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Charles River Labs (CRL) Number Cut at Jefferies on Slower Start; 'Buy' Maintained
May 1, 2014 10:46 AM EDTJefferies analyst David Windley lowered estimates and his price target on Buy-rated Charles River Labs (NYSE: CRL) to $66.00 (from $73.00) following Q1 results which showed a slower start to the year.
Windley comments, "CRL's results met internal expectations, but they fell shy of ours.... More



